Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Food for Thought: The Power of Decentralized Clinical Trials in Accelerating Infant Formula Studies By Betsy Reid June 20, 2023 Medical and Regulatory Affairs Rare Oncology and the FDA: Taking the Guesswork Out of Expedited Pathways By Rupa Doshi June 7, 2023 Development Strategy Advancing from Research to Development: What Can Go Wrong? By Alain Guimond May 19, 2023 Clinical ResearchPhase 1 - Phase 4 In Silico Modeling Unveils a New Era in Rare Disease Drug Development By Abie Ekangaki May 4, 2023 Clinical ResearchPhase 1 - Phase 4 Beyond Boundaries: Revolutionary CAR-T Therapies Pave Way to Conquer Solid Tumors By Ayesha Pandit April 24, 2023 Clinical ResearchPhase 1 - Phase 4 To Placebo or Not to Placebo? The Great Debate in Rare Disease Trials By Jaclyn Brown March 31, 2023 Previous 1 2 3 4 … 52 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today
